Photodynamic therapy in treating patients with skin cancer

Journal of Drugs in Dermatology, Nov, 2007

Sponsors and Collaborators: Roswell Park Cancer Institute and National Cancer Institute (NCI). This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.

Condition        Intervention               Phase

Nonmelanomatous  Drug: aminolevulinic acid  Phase II
  Skin Cancer    Procedure: laser therapy
Precancerous/    Procedure: photodynamic
  Nonmalignant     therapy
  Condition      Procedure: phototherapy

Study ID Numbers: CDR0000065494; RPCI-DS-96-55; NCI-G97-1224

ClinicalTrials.gov Identifier: NCT00002975

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale